166 related articles for article (PubMed ID: 36118868)
21. Oncogenic signaling pathway-related long non-coding RNAs for predicting prognosis and immunotherapy response in breast cancer.
Li H; Liu H; Hao Q; Liu X; Yao Y; Cao M
Front Immunol; 2022; 13():891175. PubMed ID: 35990668
[TBL] [Abstract][Full Text] [Related]
22. Identification of the Prognostic Significance of Somatic Mutation-Derived LncRNA Signatures of Genomic Instability in Lung Adenocarcinoma.
Geng W; Lv Z; Fan J; Xu J; Mao K; Yin Z; Qing W; Jin Y
Front Cell Dev Biol; 2021; 9():657667. PubMed ID: 33855028
[No Abstract] [Full Text] [Related]
23. Calculated identification of mutator-derived lncRNA signatures of genomic instability to predict the clinical outcome of muscle-invasive bladder cancer.
Liang Y; Ye F; Cheng Z; Ou Y; Zou L; Hu Y; Hu J; Jiang H
Cancer Cell Int; 2021 Sep; 21(1):476. PubMed ID: 34496843
[TBL] [Abstract][Full Text] [Related]
24. Development of genomic instability-associated long non-coding RNA signature: A prognostic risk model of clear cell renal cell carcinoma.
Jiang D; Wu T; Shi N; Shan Y; Wang J; Jiang H; Wu Y; Wang M; Li J; Liu H; Chen M
Front Oncol; 2022; 12():1019011. PubMed ID: 36387102
[TBL] [Abstract][Full Text] [Related]
25. Identification of LncRNA Prognostic Signature Associated With Genomic Instability in Pancreatic Adenocarcinoma.
Zhu J; Huang Q; Peng X; Luo C; Liu S; Liu Z; Wu X; Luo H
Front Oncol; 2022; 12():799475. PubMed ID: 35433487
[TBL] [Abstract][Full Text] [Related]
26. Comprehensive analysis of somatic mutator-derived and immune infiltrates related lncRNA signatures of genome instability reveals potential prognostic biomarkers involved in non-small cell lung cancer.
Yang CZ; Yang T; Liu XT; He CF; Guo W; Liu S; Yao XH; Xiao X; Zeng WR; Lin LZ; Huang ZY
Front Genet; 2022; 13():982030. PubMed ID: 36226174
[No Abstract] [Full Text] [Related]
27. A genomic instability-related lncRNA model for predicting prognosis and immune checkpoint inhibitor efficacy in breast cancer.
Jiao Y; Li S; Wang X; Yi M; Wei H; Rong S; Zheng K; Zhang L
Front Immunol; 2022; 13():929846. PubMed ID: 35990656
[TBL] [Abstract][Full Text] [Related]
28. Development and Validation of Genome Instability-Associated lncRNAs to Predict Prognosis and Immunotherapy of Patients With Hepatocellular Carcinoma.
Yan Y; Ren L; Liu Y; Liu L
Front Genet; 2021; 12():763281. PubMed ID: 35154241
[TBL] [Abstract][Full Text] [Related]
29. A Novel Model Based on Genomic Instability-Associated Long Non-Coding RNAs for Predicting Prognosis and Response to Immunotherapy in Patients With Lung Adenocarcinoma.
Tu G; Peng W; Cai Q; Zhao Z; Peng X; He B; Zhang P; Shi S; Wang X
Front Genet; 2021; 12():720013. PubMed ID: 34777461
[No Abstract] [Full Text] [Related]
30. Multi-Omics Analysis Based on Genomic Instability for Prognostic Prediction in Lower-Grade Glioma.
Cao Y; Zhu H; Liu W; Wang L; Yin W; Tan J; Zhou Q; Xin Z; Huang H; Xie D; Zhao M; Jiang X; Peng J; Ren C
Front Genet; 2021; 12():758596. PubMed ID: 35069679
[No Abstract] [Full Text] [Related]
31. A Genomic Instability-Related Long Noncoding RNA Signature for Predicting Hepatocellular Carcinoma Prognosis.
Lu J; Cao W; He Z; Wang H; Hao J; Xu J
J Oncol; 2022; 2022():3090523. PubMed ID: 36072979
[TBL] [Abstract][Full Text] [Related]
32. Identification of metabolism-related long non-coding RNA (lncRNA) signature predicts prognosis and immune infiltrates in hepatocellular carcinoma.
Wang X; Qian J; Yao N; Pocha C; Kang KJ; Angelico R; Zhu G
Ann Transl Med; 2022 May; 10(10):595. PubMed ID: 35722420
[TBL] [Abstract][Full Text] [Related]
33. Identification of the immune cell infiltration landscape in pancreatic cancer to assist immunotherapy.
Wang Z; Zou W; Wang F; Zhang G; Chen K; Hu M; Liu R
Future Oncol; 2021 Nov; 17(31):4131-4143. PubMed ID: 34346253
[TBL] [Abstract][Full Text] [Related]
34. Cuproptosis-related LncRNAs signature as biomarker of prognosis and immune infiltration in pancreatic cancer.
Chen H; Yu Y; Zhou L; Chen J; Li Z; Tan X
Front Genet; 2023; 14():1049454. PubMed ID: 36713077
[No Abstract] [Full Text] [Related]
35. Bioinformatics profiling utilized a nine immune-related long noncoding RNA signature as a prognostic target for pancreatic cancer.
Wei C; Liang Q; Li X; Li H; Liu Y; Huang X; Chen X; Guo Y; Li J
J Cell Biochem; 2019 Sep; 120(9):14916-14927. PubMed ID: 31016791
[TBL] [Abstract][Full Text] [Related]
36. Characterization of tumor immune microenvironment and cancer therapy for head and neck squamous cell carcinoma through identification of a genomic instability-related lncRNA prognostic signature.
Jing L; Du Y; Fu D
Front Genet; 2022; 13():979575. PubMed ID: 36105083
[TBL] [Abstract][Full Text] [Related]
37. Computational construction of TME-related lncRNAs signature for predicting prognosis and immunotherapy response in clear cell renal cell carcinoma.
Zhou L; Fang H; Guo F; Yin M; Long H; Weng G
J Clin Lab Anal; 2022 Aug; 36(8):e24582. PubMed ID: 35808868
[TBL] [Abstract][Full Text] [Related]
38. Genome Instability-Associated Long Non-Coding RNAs Reveal Biomarkers for Glioma Immunotherapy and Prognosis.
Wang X; Zhang H; Ye J; Gao M; Jiang Q; Zhao T; Wang S; Mao W; Wang K; Wang Q; Chen X; Hou X; Han D
Front Genet; 2022; 13():850888. PubMed ID: 35571034
[TBL] [Abstract][Full Text] [Related]
39. A novel 8-genome instability-associated lncRNAs signature predicting prognosis and drug sensitivity in gastric cancer.
Yi C; Zhang X; Chen X; Huang B; Song J; Ma M; Yuan X; Zhang C
Int J Immunopathol Pharmacol; 2022; 36():3946320221103195. PubMed ID: 35696730
[TBL] [Abstract][Full Text] [Related]
40. Identification and characterization of a 25-lncRNA prognostic signature for early recurrence in hepatocellular carcinoma.
Fu Y; Wei X; Han Q; Le J; Ma Y; Lin X; Xu Y; Liu N; Wang X; Kong X; Gu J; Tong Y; Wu H
BMC Cancer; 2021 Oct; 21(1):1165. PubMed ID: 34717566
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
